New York State Senators Luis Sepulveda (D) and Robert Rolison (R) introduced Senate Bill 5809 today, a bipartisan measure that would expand the sale of products containing hemp-derived cannabinoids.
Gummies made with hemp-derived Delta-8 THC.
The legislation would allow licensed retailers to sell all forms of cannabinoid hemp products starting January 1, 2026, as long as they meet established safety standards. The bill, which has been referred to the Senate Investigations and Government Operations Committee, would repeal emergency regulations adopted by the Office of Cannabis Management, which currently limit the types of cannabinoid hemp products available for sale.
Additionally, SB 5809 proposes refining the definition of “Total THC” within state cannabis law, clarifying that it refers only to the dry weight percentage of Delta-9 THC in each product. The changes are intended to provide greater clarity for retailers and consumers while ensuring compliance with safety guidelines.
The measure states that “The cannabis control board shall have the authority to promulgate any rules necessary to ensure the safety of cannabinoid hemp, so long as said rules do not infringe upon the ability of licensed hemp retailers to sell cannabinoid hemp. Any prior or future rules, policies, or regulations promulgated by the board or any other rulemaking body to prohibit the selling of any form of cannabinoid hemp shall be null and void.”
All hemp-derived cannabinoid products would be required to meet the following labeling requirements:
(a) Nutrition label with serving size
(b) A warning label that the product is not meant to treat or cure any medical ailment and that it is not regulated by the FDA
(c) The amount of hemp-derived product in each serving in milligrams
(d) The address of the manufacturer or distributor
For the full text of the proposed law, click here.
